Bax/Bcl-2 protein expression ratio and leukocyte function are related to reduction of Walker-256 tumor growth after β-hydroxy-β-methylbutyrate (HMB) administration in Wistar rats.

Nutrition and cancer

Volumn 64, Issue 2, 2012, Pages 286-293

  Kuczera, Diogo ^a   Paro de Oliveira, Heloísa Helena ^b   Fonseca Guimarães, Fernando de Souza ^b   de Lima, Carina ^b   Alves, Luciana ^b   Machado, Andressa Franzói ^b   Coelho, Isabela ^b   Yamaguchi, Adriana ^b   Donatti, Lucélia ^b   Naliwaiko, Katya ^b   Fernandes, Luiz Claudio ^b   Nunes, Everson Araújo ^b  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYISOVALERIC ACID; ANTINEOPLASTIC AGENT; BETA-HYDROXYISOVALERIC ACID; PROTEIN BAX; PROTEIN BCL 2; VALERIC ACID DERIVATIVE;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; CARCINOMA; CELL PROLIFERATION; CHEMISTRY; DRUG EFFECT; MALE; NEUTROPHIL; PATHOLOGY; PHYSIOLOGY; RAT; TRANSMISSION ELECTRON MICROSCOPY; WISTAR RAT;

ANIMALS; ANTINEOPLASTIC AGENTS; BCL-2-ASSOCIATED X PROTEIN; CARCINOMA 256, WALKER; CELL PROLIFERATION; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; NEOPLASM TRANSPLANTATION; NEUTROPHILS; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, WISTAR; VALERATES;

EID: 84862248713     PISSN: None     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.647229     Document Type: Article

References (0)